ArsenalBio Funding & Investors

ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases, initially cancer.

Total Amount Raised: $305,806,688

ArsenalBio Funding Rounds

Series A
$85,000,000
Oct 16, 2019
Series A Investors
UCSF Foundation Investment Company
Westlake Village BioPartners
Osage University Partners
Euclidean Capital
Parker Institute for Cancer Immunotherapy
Kleiner Perkins Caufield & Byers
University of California
Series B
$220,806,682
Sep 5, 2022
Series B Investors
Hitachi Ventures
SoftBank Investment Advisers
Green Sands Equity
Bristol-Myers Squibb
UCSF
Waycross Ventures
Emerson Collective
Sixth Street
Westlake Village BioPartners
Triatomic Capital
Byers Capital
Euclidean Capital
Parker Institute for Cancer Immunotherapy
Kleiner Perkins Caufield & Byers

Funding info provided by Diffbot.